Literature DB >> 15876250

Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles.

E Kuchinskaya1, M Heyman, D Grandér, M Linderholm, S Söderhäll, A Zaritskey, A Nordgren, A Porwit-Macdonald, E Zueva, Y Pawitan, M Corcoran, M Nordenskjöld, E Blennow.   

Abstract

OBJECTIVES: To compare the gene expression pattern in children and adults with acute lymphoblastic leukaemia (ALL) in order to improve our understanding of the difference in disease biology and prognosis.
METHODS: The gene expression profiles in diagnostic samples from 29 children and 15 adults with ALL were analysed using the oligonucleotide chip Hu95ver2a, produced by Affymetrix.
RESULTS: Unsupervised hierarchical cluster analysis revealed that, in spite of differences in outcome, patients clustered irrespective of age, first by T-cell or B-precursor immunophenotype, and second by cytogenetic changes within the B-precursor group. The expression pattern analysis allowed the reclassification of some samples into the proper cytogenetic group. We also showed that separate clustering of samples with the BCR/ABL translocation could be explained by different breakpoint regions in the BCR. No significant difference in gene expression was observed between samples with and without CDKN2A deletion within the B-precursor group. Analysis of different age groups revealed a similarity in expression profiles when infants with the MLL translocation and adults over 40 yr of age were compared irrespective of karyotype.
CONCLUSIONS: In spite of the difference in clinical outcome, the gene expression pattern in children and adults with ALL is very similar and is primarily dependent on immunophenotype and cytogenetic aberrations. However, when age groups are compared, the expression patterns of infants and adults over 40 show a remarkable similarity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876250     DOI: 10.1111/j.1600-0609.2005.00433.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.

Authors:  Kristie A Blum; Frank G Keller; Sharon Castellino; Anh Phan; Christopher R Flowers
Journal:  Br J Haematol       Date:  2018-08-10       Impact factor: 6.998

Review 2.  Approaches to treatment for acute lymphoblastic leukemia in adolescents and young adults.

Authors:  Ryan Mattison; Wendy Stock
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

3.  Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.

Authors:  Miroslav Djokic; Elisabet Björklund; Elisabeth Blennow; Joanna Mazur; Stefan Söderhäll; Anna Porwit
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

4.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

Authors:  Wendy Stock; Mei La; Ben Sanford; Clara D Bloomfield; James W Vardiman; Paul Gaynon; Richard A Larson; James Nachman
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113

5.  A Novel Acquired t(2;4)(q36.1;q24) with a Concurrent Submicroscopic del(4)(q23q24) in An Adult with Polycythemia Vera.

Authors:  Eigil Kjeldsen
Journal:  Cancers (Basel)       Date:  2018-06-25       Impact factor: 6.639

6.  TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.

Authors:  Jit Kong Cheong; Lakshman Gunaratnam; Zhi Jiang Zang; Christopher M Yang; Xiaoming Sun; Susan L Nasr; Khe Guan Sim; Bee Keow Peh; Suhaimi Bin Abdul Rashid; Joseph V Bonventre; Manuel Salto-Tellez; Stephen I Hsu
Journal:  J Transl Med       Date:  2009-01-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.